Ingela Fehrman-Ekholm

Publications
Public outreach and news

Articles

Article: CLINICAL KIDNEY JOURNAL. 2017;10(3):310-319

Current evidence on the discontinuation of eculizumab in patients with atypical haemolytic uraemic syndrome.

Macia M; de Alvaro Moreno F; Dutt T; Fehrman I; Hadaya K; Gasteyger C; Heyne N
Article: LAKARTIDNINGEN. 2014;111(5):154-157

[Pregnancy and childbirth is now possible for women with chronic kidney disease. Dialysis treatment should be intensified during pregnancy, as shown in five cases].

Ståhl M; Wendt M; Mielniczenko G; Sennström M; Fehrman-Ekholm I
Article: HEMODIALYSIS INTERNATIONAL. 2013;17(3):366-373

The effects of hemodialysis treatment on the level of DNA strand breaks and oxidative DNA lesions measured by the comet assay

Ersson C; Odar-Cederlof I; Fehrman-Ekholm I; Moller L
Article: CLINICAL TRANSPLANTS. 2013;:181-186

View from a living donor.

Fehrman-Ekholm I
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2011;26(7):2377-2381

Post-nephrectomy development of renal function in living kidney donors: a cross-sectional retrospective study.

Fehrman-Ekholm I; Kvarnström N; Söfteland JM; Lennerling A; Rizell M; Odén A; Simonsson T
Article: CLINICAL TRANSPLANTS. 2011;:119-125

Kidney transplantation--a 46-year experience from the Transplant Institute, Sahlgrenska University Hospital, Gothenburg, Sweden.

Friman S; Nordén G; Lennerling A; Fehrman-Ekholm I; Felldin M; Hansson S; Rydberg L; Holgersson J; Rizell M; Kvarnström N; Gustafsson B; Gäbel M; Olausson M; Mjörnstedt L
Article: TRANSPLANT INTERNATIONAL. 2009;22(11):1051-1057

Variations in graft and patient survival after kidney transplantation in Sweden: caveats in interpretation of center effects when benchmarking

Elinder C-G; Ekberg H; Barany P; Fehrman-Ekholm I; Jensen G; Norden G; Schon S; Wennberg L; Qureshi AR
Article: AMERICAN JOURNAL OF KIDNEY DISEASES. 2009;53(6):1024-1033

Comorbidity and Acute Clinical Events as Determinants of C-Reactive Protein Variation in Hemodialysis Patients: Implications for Patient Survival

Snaedal S; Heimburger O; Qureshi AR; Danielsson A; Wikstrom B; Fellstrom B; Fehrman-Ekholm I; Carrero JJ; Alvestrand A; Stenvinkel P; Barany P
Article: SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION. 2009;69(5):606-611

Serum cystatin C: A useful marker of kidney function in very old people

Fehrman-Ekholm I; Seeberger A; Bjork J; Sterner G
Article: CLINICAL TRANSPLANTATION. 2008;22(3):304-308

Nondirected living kidney donation: experiences in a Swedish Transplant Centre.

Lennerling A; Fehrman-Ekholm I; Nordén G
Article: SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY. 2008;42(1):74-80

Concentrations of vitamin C, vitamin B12 and folic acid in patients treated with hemodialysis and on-line hemodiafiltration or hemofiltration

Fehrman-Ekholm I; Lotsander A; Logan K; Dunge D; Odar-Cederlof I; Kallner A
Article: TRANSPLANTATION. 2006;82(12):1646-1648

Incidence of end-stage renal disease among live kidney donors.

Fehrman-Ekholm I; Nordén G; Lennerling A; Rizell M; Mjörnstedt L; Wramner L; Olausson M
Article: INTERNATIONAL JOURNAL OF COLORECTAL DISEASE. 2006;21(6):493-504

Down-regulation of interferon-γ parallels clinical response to selective leukocyte apheresis in patients with inflammatory bowel disease:: a 12-month follow-up study

Muratov V; Lundahl J; Ulfgren AK; Elvin K; Fehrman I; Ahlborg N; Ost A; Hittel N; Saniabadi A; Lofberg R
Article: KIDNEY INTERNATIONAL. 2006;69(6):981-988

Phenotypic expression of factor H mutations in patients with atypical hemolytic uremic syndrome

Vaziri-Sani F; Holmberg L; Sjöholm AG; Kristoffersson AC; Manea M; Frémeaux-Bacchi V; Fehrman-Ekholm I; Raafat R; Karpman D
Article: AMERICAN JOURNAL OF TRANSPLANTATION. 2005;5(1):145-148

ABO incompatible kidney transplantations without splenectomy, using antigen-specific immunoadsorption and rituximab

Tydén G; Kumlien G; Genberg H; Sandberg J; Lundgren T; Fehrman I
Article: SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY. 2004;38(1):73-77

Renal function in the elderly (>70 years old) measured by means of iohexol clearance, serum creatinine, serum urea and estimated clearance.

Fehrman-Ekholm I; Skeppholm L
Article: TRANSPLANTATION. 2003;76(4):730-731

Successful ABO-incompatible kidney transplantations without splenectomy using antigen-specific immunoadsorption and rituximab

Tydén G; Kumlien G; Fehrman I
Article: AMERICAN JOURNAL OF KIDNEY DISEASES. 2003;41(6):1212-1218

Associations between circulating inflammatory markers and residual renal function in CRF patients

Pecoits R; Heimbürger O; Bárány P; Suliman M; Fehrman-Ekholm I; Lindholm B; Stenvinkel P
Article: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2003;14(6):1614-1622

Plasma pentosidine is associated with inflammation and malnutrition in end-stage renal disease patients starting on dialysis therapy

Suliman ME; Heimbürger O; Bárány P; Anderstam B; Pecoits R; Ayala ER; Qureshi AR; Fehrman-Ekholm I; Lindholm B; Stenvinkel P
Article: TRANSPLANTATION. 2001;72(3):444-449

No evidence of accelerated loss of kidney function in living kidney donors:: Results from a cross-sectional follow-up

Fehrman-Ekholm I; Dunér F; Brink B; Tydén G; Elinder CG
Article: TRANSPLANTATION. 2000;69(10):2067-2071

Kidney donors don't regret -: Follow-up of 370 donors in Stockholm since 1964

Fehrman-Ekholm I; Brink B; Ericsson C; Elinder CG; Dunér F; Lundgren G
Article: INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS. 1999;22(2):81-87

Plasma exchange or immunoadsorption in patients with rapidly progressive crescentic glomerulonephritis. A Swedish multi-center study.

Stegmayr BG; Almroth G; Berlin G; Fehrman I; Kurkus J; Norda R; Olander R; Sterner G; Thysell H; Wikström B; Wirén JE
Article: TRANSPLANTATION. 1997;64(7):976-978

Kidney donors live longer

FehrmanEkholm I; Elinder CG; Stenbeck M; Tyden G; Groth CG
Article: TRANSPLANTATION. 1996;61(8):1264-1265

Reasons for not accepting living kidney donors.

Fehrman-Ekholm I; Gabel H; Magnusson G
Article: JOURNAL OF INTERNAL MEDICINE. 1996;239(2):177-180

Increased prevalence of atherosclerotic wall changes in patients with hyperlipidaemia after renal transplantation.

Jogestrand T; Fehrman-Ekholm I; Angelin B; Berglund L; Gäbel H
Show more

All other publications

Other: TRANSPLANTATION. 2018;102(9S Suppl 1):S1-S14

Long-term Challenges After Solid Organ Transplantation: Summary of Expert Presentations From the Sandoz 5th Standalone Transplantation Meeting, 2017.

Legendre C; Viebahn R; Fehrman-Ekholm I; Masnou N; Berenguer M; Potena L; Wennberg L; O'Grady J; Epailly E; Diekmann F; Binet I; Schwenger V; Kuypers D; Guthoff M
Letter: LAKARTIDNINGEN. 2013;110(48):2157

[Is it ethical to compensate for kidney donation?].

Fehrman-Ekholm I
Published conference paper: TRANSPLANTATION PROCEEDINGS. 2012;44(7):2246-2249

Living donor psychosocial assesment/follow-up practices in the partners' countries of the ELIPSY project.

Manyalich M; Menjívar A; Yucetin L; Peri JM; Torres X; Dias L; Hiesse C; Papachristou C; Fehrman-Ekholm I; Kvarnström N; Ballesté C; Paredes D; Revuelta I; Diekmann F; Rimola A; Fondevila C; Martínez M; Legendre C; Pereira RC; Carvalho IA; Lopes A
Published conference paper: TRANSPLANTATION PROCEEDINGS. 2010;42(10):4449-4454

Long-Term Follow-up of Living Liver Donors

Castedal M; Andersson M; Polanska-Tamborek D; Friman S; Olausson M; Fehrman-Ekholm I
Other: INTERNATIONAL JOURNAL OF NEPHROLOGY. 2010;2010:817836-4

Recovery of renal function after one-year of dialysis treatment: case report and registry data.

Fehrman-Ekholm I; Bergenhag A-C; Heimburger O; Schön S
Published conference paper: TRANSPLANTATION PROCEEDINGS. 2009;41(2):764-765

Single or double arteries in the remnant kidney after donation: influence on the long-term outcome of the donor.

Fehrman-Ekholm I; Möller S; Steinwall J; Nordén G; Lennerling A; Holmdahl J; Kvarnström N; Olausson M
Editorial comment: BMJ-BRITISH MEDICAL JOURNAL. 2007;335(7633):1305

Death delusion

Hellden A; Odar-Cederlof I; Larsson K; Fehrman-Ekholm I; Linden T
Published conference paper: TRANSPLANTATION PROCEEDINGS. 2006;38(8):2642-2643

Living kidney donors developing end-stage renal disease.

Fehrman-Ekholm I; Nordén G; Lennerling A; Rizell M; Herlitz H; Nielsen F-D; Storkamp O; Deurell S-I; Olausson M
Published conference paper: TRANSPLANTATION PROCEEDINGS. 2006;38(8):2637-2641

Living donor kidney transplantation.

Fehrman-Ekholm I
Published conference paper: XENOTRANSPLANTATION. 2006;13(2):105-107

The Stockholm experience with ABO-incompatible kidney transplantations without splenectomy

Tydén G; Kumlien G; Genberg H; Sandberg J; Sedigh A; Lundgren T; Gjertsen H; Fehrman I
Published conference paper: TRANSPLANTATION PROCEEDINGS. 2005;37(8):3286-3287

ABO-incompatible kidney transplantation and rituximab

Tydén G; Kumlien G; Genberg H; Sandberg J; Lundgren T; Fehrman I
Editorial comment: TRANSPLANTATION. 2004;78(6):787

Donors need support too

Fehrman-Ekholm I; Tydén G
Letter: NEPHROLOGY DIALYSIS TRANSPLANTATION. 1998;13(11):2982-2983

A successful pregnancy in a kidney recipient with tacrolimus (Prograf, FK 506) therapy.

Fehrman-Ekholm I; Nisell H
Published conference paper: TRANSPLANTATION PROCEEDINGS. 1997;29(7):2801-2802

Life-span of living-related kidney donors.

Fehrman-Ekholm I
Published conference paper: TRANSPLANTATION PROCEEDINGS. 1997;29(1-2):1481

Long-term survival of living related kidney donors

FehrmanEkholm I; Johansson A; Konberg A; Tyden G
Published conference paper: TRANSPLANTATION PROCEEDINGS. 1997;29(1-2):280-283

The Swedish nationwide experience of converting transplant patients treated with sandimmun to the new galenic formulation sandimmun-neoral

Wilczek HE; Berglin E; Blohme I; Backman L; Fehrman I; Kallen R; Nyberg G; Sawe J; Wahlberg J
Letter: NEPHRON. 1996;72(3):483

Decreased cyclosporine levels during gemfibrozil treatment of hyperlipidemia after kidney transplantation

FehrmanEkholm I; Jogestrand T; Angelin B
Published conference paper: TRANSPLANTATION PROCEEDINGS. 1995;27(6):3526

Reasons for non-acceptance of living kidney donors.

Fehrman-Ekholm I; Gäbel H

Articles

All other publications

News from KI

Events from KI